-
Diminazene Aceturate Research Workflows
2026-09-02
Diminazene Aceturate supports two distinct research paths: trypanosome parasite screening and mechanism-focused ACE2 activation studies. This workflow-led guide covers formulation, controls, mitochondrial readouts, and troubleshooting while keeping preclinical findings separate from clinical claims.
-
TAK-715: A Practical p38 MAPK Inhibitor Workflow
2026-09-01
TAK-715 combines nanomolar p38α inhibition with a useful experimental profile for cytokine, inflammation, and rheumatoid arthritis research. This workflow explains how to prepare, dose, validate, and troubleshoot the compound while separating established product data from emerging dual-action mechanistic hypotheses.
-
Pioglitazone: PPARγ Agonist Research Guide
2026-09-01
Pioglitazone is a selective PPARγ agonist for studying insulin sensitivity, beta-cell protection, macrophage polarization, and inflammatory signaling. Evidence from receptor assays and a DSS-induced intestinal inflammation model connects PPARγ activation with metabolic regulation and STAT-1/STAT-6 pathway changes.
-
Standardized Whole-Blood Stimulation for Immunometabolism
2026-08-31
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with targeted metabolic interventions and cytokine measurement. The workflow offers a reproducible way to study how metabolic pathways selectively shape human immune responses while clarifying the controls needed for cohort-scale and translational studies.
-
Salinomycin Workflows for HCC Research
2026-08-31
Build a more interpretable Salinomycin workflow by connecting ion transport, Wnt/β-catenin signaling, calcium flux, and apoptosis rather than relying on viability alone. This practical framework differentiates formulation, timing, and mechanism-testing decisions for hepatocellular carcinoma research.
-
Adiponectin, TLR4, and Cognitive Deficits After Surgery
2026-08-30
This reference study identifies suppression of the TLR4/MyD88/NF-κB axis as a potential mechanism by which adiponectin protects aged rats from splenectomy-associated cognitive impairment. Pharmacological inhibition with TAK-242 and pathway reversal with LPS strengthen the proposed link between neuroinflammation, oxidative stress, and postoperative cognitive dysfunction, while also defining important limits for translation.
-
FCCP: Mitochondrial Uncoupling Workflows
2026-08-29
Use FCCP to connect mitochondrial respiration with ATP loss, HIF signaling, and organelle quality-control phenotypes. This practical guide translates the MARCH5 pre-peroxisome study into dose-controlled workflows for mitochondrial biology research, metabolic regulation studies, and cancer models.
-
Maternal IL-17A and Neonatal GBS Risk
2026-08-28
A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses with invasive Group B Streptococcus disease in newborns. By combining clinical cytokine profiling with ex vivo TLR1/2 and TLR4 stimulation, the study positions maternal IL-17A as a candidate risk-stratification biomarker rather than a marker of colonization alone.
-
HAUS1, Immune Contexture, and HCC Prognosis
2026-08-28
The reference study integrates public cancer datasets, immune-infiltration analyses, survival modeling, and siRNA experiments to define HAUS1 as a clinically relevant factor in hepatocellular carcinoma (HCC). Its findings connect elevated HAUS1 with adverse disease features, tumor-cell proliferation, and an immunologically relevant tumor environment, while also identifying limitations that require prospective and mechanistic validation.
-
Aprotinin in Protease-Controlled RNA Workflows
2026-08-27
Aprotinin adds a testable serine-protease control layer to nuclei, plasma, and inflammation workflows without changing the core readout. This article translates the rRNA-depleted GRO-seq strategy into practical assay design while separating established evidence from research-use-only optimization.
-
Cholesterol in mRNA-LNP Workflows
2026-08-27
Cholesterol is a controllable membrane variable for mRNA-LNP formulation, fluidity testing, and localized delivery studies. This practical guide connects solvent handling and assay design with the intravesical p21 mRNA-LNP strategy while distinguishing published findings from optimization recommendations.
-
Mitocytosis and Mitochondrial Antimetastatic Therapy
2026-08-26
Deng and colleagues show that mitocytosis can weaken mitochondria-targeted antimetastatic therapy in migrasome-rich breast tumors. Their hybrid membrane nanoplatform combines mitochondrial damage with integrin-mediated mitocytosis inhibition, offering a mechanistic strategy to improve treatment response in the 4T1 model.
-
Melatonin-SCNF Hydrogel for Atopic Dermatitis
2026-08-26
The reference study develops a melatonin-loaded sacchachitin nanofiber hydrogel as a non-steroidal topical platform for atopic dermatitis and evaluates it in a DNCB-induced NC/Nga mouse model. Its findings indicate that sacchachitin nanofibers mainly provide structural and adhesive support, while melatonin drives the observed reductions in disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated biomarkers.
-
Maternal IL-17A and Neonatal GBS Risk
2026-08-25
A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses with invasive neonatal Group B Streptococcus disease among colonized pregnancies. The findings position circulating IL-17A as a candidate risk biomarker and show how ex vivo pattern-recognition receptor stimulation can complement clinical cytokine profiling.
-
PAD4-IN-2 TFA: Designing Better NET Assays
2026-08-25
PAD4-IN-2 TFA, also known as Compound 5i TFA, enables tumor-directed investigation of PAD4, histone H3 citrullination, and NET biology. This guide focuses on assay logic, orthogonal controls, and how to distinguish tumor-cell migration effects from neutrophil-mediated mechanisms.